1
|
Park JW, Jeon J, Kim GB, Jeong KH. Fully Integrated Ultrathin Solid Immersion Grating Microspectrometer for Handheld Visible and Near-Infrared Spectroscopic Applications. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2023; 10:e2304320. [PMID: 37849223 DOI: 10.1002/advs.202304320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 09/06/2023] [Indexed: 10/19/2023]
Abstract
Despite advances in microfabrication, compact spectrometers still face challenges in shrinking their size without sacrificing optical performance. Here, the solid immersion grating microspectrometer (SIG-µSPEC) for high spectral resolution in a broad operational wavelength range is reported. The spectroscopic module incorporates a silicon microslit, index-matched lens, plane mirrors, solid immersion grating (SIG), and a CMOS line sensor within a small form factor. The SIG facilitates high angular dispersion of light on a planar focal plane, resulting in an average spectral resolution of 5.8 nm, with over 76% maximum sensitivity from 400 to 800 nm. SIG-µSPEC measures the spectral reflectance of fruits at different ripening stages, clearly revealing changes in the chlorophyll absorption band. The measured spectrum is further utilized for the precise prediction of the soluble solid content (SSC) levels, achieving a high correlation (R2 = 0.91) and a ratio of prediction-to-deviation of 2.36. This compact microspectrometer holds the potential for precise and non-invasive spectral analysis across point-of-care fields.
Collapse
Affiliation(s)
- Jung-Woo Park
- Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea
- KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea
| | - Jaehun Jeon
- Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea
- KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea
| | - Gi Beom Kim
- Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea
- KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea
| | - Ki-Hun Jeong
- Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea
- KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea
| |
Collapse
|
2
|
Dowek A, Voisin F, Le L, Tan C, Mallet J, Carn F, Caudron E. Self-assembly of gold nanoparticles by chitosan for improved epinephrine detection using a portable surface enhanced Raman scattering device. Talanta 2023; 251:123752. [DOI: 10.1016/j.talanta.2022.123752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 07/13/2022] [Accepted: 07/15/2022] [Indexed: 10/17/2022]
|
3
|
Rayyad A, Makki AA, Chourpa I, Massot V, Bonnier F. Quantification of clinical mAb solutions using Raman spectroscopy: Macroscopic vs microscopic analysis. Talanta 2022; 250:123692. [PMID: 35777345 DOI: 10.1016/j.talanta.2022.123692] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Revised: 06/09/2022] [Accepted: 06/13/2022] [Indexed: 11/28/2022]
Abstract
Raman Spectroscopy is well emerged in the field of Analytical Quality Control (AQC) as a rapid and cost-effective technique useful in many applications. The advantage of Raman spectroscopy is the non-invasiveness of measurements that enablesto analyse samples directly in its container. In this study, the potential of Raman spectroscopy was investigated for analysis of clinical preparations of mAbs. Three commercial formulations of monoclonal antibodies (mAbs) Avastin®, Ontruzant® and Tecentriq® corresponding to Bevacizumab (BVC), Trastuzumab (TRS) and Atezolizumab (ATZ) respectively, were analysed in quartz cuvette in macroscopic analysis and through the wall of perfusion bags in microscopic analysis. The spectra have been compared to those of excipients (trehalose and sucrose) and of γ-Globulin, in order to investigate the origin of Raman bands. As expected, Raman spectra were a combination of bands from monoclonal antibodies and correspoding excipients found in formulas. For quantitative analysis of the solutions, models have been constructed using Partial Least Square Regression (PLSR) with Leave K-Out Cross Validation (LKOCV). The quantification performance was comparable for both macroscopic and microscopic analysis, in terms of error and linearity. The results are thus promising for future AQC in situ, in perfusion bags.
Collapse
Affiliation(s)
- Ayyoub Rayyad
- EA 6295 Nanomédicaments et Nanosondes, Faculté de Pharmacie, Université de Tours, 31 Avenue Monge, 37200, Tours, France
| | - Alaa A Makki
- University of Gezira, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, P.O. Box 20, 21111, Wad Madani, Sudan
| | - Igor Chourpa
- EA 6295 Nanomédicaments et Nanosondes, Faculté de Pharmacie, Université de Tours, 31 Avenue Monge, 37200, Tours, France
| | - Victor Massot
- CHU de Tours, Unité de Biopharmacie Clinique Oncologique, Pharmacie, France
| | - Franck Bonnier
- EA 6295 Nanomédicaments et Nanosondes, Faculté de Pharmacie, Université de Tours, 31 Avenue Monge, 37200, Tours, France.
| |
Collapse
|
4
|
Luiz MT, Dutra JAP, Di Filippo LD, Junior AGT, Tofani LB, Marchetti JM, Chorilli M. Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems. Crit Rev Anal Chem 2021; 53:1080-1093. [PMID: 34818953 DOI: 10.1080/10408347.2021.2007469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/21/2023]
Abstract
Epirubicin (EPI) is a chemotherapeutic agent belonging to the anthracycline drug class indicated for treating several tumors. It acts by suppressing the DNA and RNA synthesis by intercalating between their base pair. However, several side effects are associated with this therapy, including cardiotoxicity and myelosuppression. Therefore, EPI delivery in nanosystems has been an interesting strategy to overcome these limitations and improve the safety and efficacy of EPI. Thus, analytical methods have been used to understand and characterize these nanosystems, including spectrophotometric, spectrofluorimetric, and chromatography. Spectrophotometric and spectrofluorimetric methods have been used to quantify EPI in less complex matrices due to their efficiency, low cost, and green chemistry character. By contrast, high-performance liquid chromatography is a suitable method for detecting EPI in more complex matrices (e.g., plasm and urine) owing to its high sensitivity. This review summarizes physicochemical and pharmacokinetic properties of EPI, its application in drug delivery nanosystems, and the analytical methods employed in its quantification in different matrices, including blood, plasm, urine, and drug delivery nanosystems.
Collapse
Affiliation(s)
- Marcela Tavares Luiz
- School of Pharmaceutical Science of Ribeirao Preto, University of São Paulo (USP), Ribeirao Preto, São Paulo, Brazil
| | | | | | | | - Larissa Bueno Tofani
- School of Pharmaceutical Science of Ribeirao Preto, University of São Paulo (USP), Ribeirao Preto, São Paulo, Brazil
| | - Juliana Maldonado Marchetti
- School of Pharmaceutical Science of Ribeirao Preto, University of São Paulo (USP), Ribeirao Preto, São Paulo, Brazil
| | - Marlus Chorilli
- School of Pharmaceutical Science of São Paulo State University (UNESP), Araraquara, São Paulo, Brazil
| |
Collapse
|
5
|
Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam. Molecules 2021; 26:molecules26195879. [PMID: 34641421 PMCID: PMC8513103 DOI: 10.3390/molecules26195879] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 09/22/2021] [Accepted: 09/23/2021] [Indexed: 11/29/2022] Open
Abstract
Medical errors associated with IV preparation and administration procedures in a hospital workflow can even cost human lives due to the direct effect they have on patients. A large number of such incidents, which have been reported in bibliography up to date, indicate the urgent need for their prevention. This study aims at proposing an analytical methodology for identifying and quantifying IV drugs before their administration, which has the potential to be fully harmonized with clinical practices. More specifically, it reports on the analysis of a piperacillin (PIP) and tazobactam (TAZ) IV formulation, using Raman spectroscopy. The simultaneous analysis of the two APIs in the same formulation was performed in three stages: before reconstitution in the form of powder without removing the substance out of the commercial glass bottle (non-invasively), directly after reconstitution in the same way, and just before administration, either the liquid drug is placed in the infusion set (on-line analysis) or a minimal amount of it is transferred from the IV bag to a Raman optic cell (at-line analysis). Except for the successful identification of the APIs in all cases, their quantification was also achieved through calibration curves with correlation coefficients ranging from 0.953 to 0.999 for PIP and from 0.965 to 0.997 for TAZ. In any case, the whole procedure does not need more than 10 min to be completed. The current methodology, based on Raman spectroscopy, outweighs other spectroscopic (UV/Vis, FT-IR/ATR) or chromatographic (HPLC, UHPLC) protocols, already applied, which are invasive, costly, time-consuming, not environmentally friendly, and require specialized staff and more complex sample preparation procedures, thus exposing the staff to hazardous materials, especially in cases of cytotoxic drugs. Such an approach has the potential to bridge the gap between experimental setup and clinical implementation through exploitation of already developed handheld devices, along with the presence of digital spectral libraries.
Collapse
|
6
|
Lee Y, Kim J, Han J, Jeong H, Woo YA, Chung H. Axially slanted laser illumination scheme for direct and accurate Raman spectroscopic determination of gemcitabine concentration in freeze-dried gemcitabine injection powder housed in a glass container. Anal Chim Acta 2021; 1175:338746. [PMID: 34330445 DOI: 10.1016/j.aca.2021.338746] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Revised: 05/08/2021] [Accepted: 06/07/2021] [Indexed: 10/21/2022]
Abstract
When Raman spectroscopy is employed for a direct in situ determination of ingredient concentration for a product stored in a glass container, minimization of the interfering glass background in the collected spectrum is demanding to secure a more accurate analysis. To meet this request, an axially slanted illumination (ASI) scheme slantingly irradiating laser on the headspace side of a glass container and positioning a detector beneath the container was demonstrated in this study. This ASI scheme was basically designed to increase the distance between the laser illumination spot and detector location to minimize the number of glass photons reaching the detector. The analytical utility of the scheme was evaluated for the determination of gemcitabine concentration (42.9-58.2 wt%) in the gemcitabine injection powder housed in a glass container. Using the ASI scheme, the spectral features of the gemcitabine powder became distinct with only a weak underlying glass background signal. For comparative purpose, when an axially perpendicular offset (APO) scheme perpendicularly irradiating laser on the side wall where the sample was filled was used, the magnitude of glass background was higher, and the most intense gemcitabine peak was largely buried in the glass peak. The accuracy for determination of gemcitabine concentration using the ASI scheme was superior with an error of 0.20 wt%, while 0.33 wt% with employing the APO scheme. Overall, this study demonstrates that the ASI scheme is a potentially versatile Raman spectroscopic tool for fast non-sampling analysis of other products stored in a glass container.
Collapse
Affiliation(s)
- Yoonjeong Lee
- Department of Chemistry and Research Institute for Convergence of Basic Science, Hanyang University, Seoul, 04763, Republic of Korea
| | - Jaejin Kim
- Chong Kun Dang Pharmaceuticals, Chungcheongnam-do, 330-831, Republic of Korea
| | - Janghee Han
- Chong Kun Dang Pharmaceuticals, Chungcheongnam-do, 330-831, Republic of Korea
| | - Haeseong Jeong
- Department of Chemistry and Research Institute for Convergence of Basic Science, Hanyang University, Seoul, 04763, Republic of Korea
| | - Young-Ah Woo
- Chong Kun Dang Pharmaceuticals, Chungcheongnam-do, 330-831, Republic of Korea.
| | - Hoeil Chung
- Department of Chemistry and Research Institute for Convergence of Basic Science, Hanyang University, Seoul, 04763, Republic of Korea.
| |
Collapse
|
7
|
Makki AA, Elderderi S, Massot V, Respaud R, Byrne HJ, Tauber C, Bertrand D, Mohammed E, Chourpa I, Bonnier F. In situ Analytical Quality Control of chemotherapeutic solutions in infusion bags by Raman spectroscopy. Talanta 2021; 228:122137. [PMID: 33773705 DOI: 10.1016/j.talanta.2021.122137] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2020] [Revised: 01/17/2021] [Accepted: 01/18/2021] [Indexed: 02/04/2023]
Abstract
Analytical Quality Control (AQC) in centralised preparation units of oncology centers is a common procedure relying on the identification and quantification of the prepared chemotherapeutic solutions for safe intravenous administration to patients. Although the use of Raman spectroscopy for AQC has gained much interest, in most applications it remains coupled to a flow injection analyser (FIA) requiring withdrawal of the solution for analysis. In addition to current needs for more rapid and cost-effective analysis, the risk of exposure of clinical staff to the toxic molecules during daily handling is a serious concern to address. Raman spectroscopic analysis, for instance by Confocal Raman Microscopy (CRM), could enable direct analysis (non-invasive) for AQC directly in infusion bags. In this study, 3 anticancer drugs, methotrexate (MTX), 5-fluorouracil (5-FU) and gemcitabine (GEM) have been selected to highlight the potential of CRM for withdrawal free analysis. Solutions corresponding to the clinical range of each drug were prepared in 5% glucose and data was collected from infusion bags placed under the Raman microscope. Firstly, 100% discrimination has been obtained by Partial Least Squares Discriminant Analysis (PLS-DA) confirming that the identification of drugs can be performed. Secondly, using Partial Least Squares Regression (PLSR), quantitative analysis was performed with mean % error of predicted concentrations of respectively 3.31%, 5.54% and 8.60% for MTX, 5-FU and GEM. These results are in accordance with the 15% acceptance criteria used for the current clinical standard technique, FIA, and the Limits of Detection for all drugs were determined to be substantially lower than the administered range, thus highlighting the potential of confocal Raman spectroscopy for direct analysis of chemotherapeutic solutions.
Collapse
Affiliation(s)
- Alaa A Makki
- Université de Tours, EA 6295 Nanomédicaments et Nanosondes, 31 Avenue Monge, 37200, Tours, France; University of Gezira, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, P.O. Box 20, 21111, Wad Madani, Sudan
| | - Suha Elderderi
- Université de Tours, EA 6295 Nanomédicaments et Nanosondes, 31 Avenue Monge, 37200, Tours, France; University of Gezira, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, P.O. Box 20, 21111, Wad Madani, Sudan
| | - Victor Massot
- CHU de Tours, Unité de Biopharmacie Clinique Oncologique, Pharmacie, France
| | - Renaud Respaud
- Université de Tours, UMR 1100, CHRU de Tours, Service de Pharmacie, F-37032, Tours, France
| | - Hugh J Byrne
- FOCAS Research Institute, TU Dublin, City Campus, Kevin Street, Dublin 8, Ireland
| | - Clovis Tauber
- Université de Tours, INSERM UMR 1253 IBrain, 37000, Tours, France
| | | | - Elhadi Mohammed
- University of Gezira, Faculty of Pharmacy, Medicinal and Aromatic Plants Research Center (MAPRC), P.O. Box 20, 21111, Wad Madani, Sudan
| | - Igor Chourpa
- Université de Tours, EA 6295 Nanomédicaments et Nanosondes, 31 Avenue Monge, 37200, Tours, France
| | - Franck Bonnier
- Université de Tours, EA 6295 Nanomédicaments et Nanosondes, 31 Avenue Monge, 37200, Tours, France.
| |
Collapse
|
8
|
El Orche A, Adade CA, Mefetah H, Cheikh A, Karrouchi K, El Karbane M, Bouatia M. Chemometric Analysis of UV-Visible Spectral Fingerprints for the Discrimination and Quantification of Clinical Anthracycline Drug Preparation Used in Oncology. BIOMED RESEARCH INTERNATIONAL 2021; 2021:5580102. [PMID: 34041297 PMCID: PMC8121585 DOI: 10.1155/2021/5580102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 04/12/2021] [Accepted: 04/29/2021] [Indexed: 11/17/2022]
Abstract
In clinical treatment, the analytical quality assessment of the delivery of chemotherapeutic preparations is required to guarantee the patient's safety regarding the dose and most importantly the appropriate anticancer drug. On its own, the development of rapid analytical methods allowing both qualitative and quantitative control of the formulation of prepared solutions could significantly enhance the hospital's workflow, reducing costs, and potentially providing optimal patient care. UV-visible spectroscopy is a nondestructive, fast, and economical technique for molecular characterization of samples. A discrimination and quantification study of three chemotherapeutic drugs doxorubicin, daunorubicin, and epirubicin was conducted, using clinically relevant concentration ranges prepared in 0.9% NaCl solutions. The application of the partial least square discriminant analysis PLS-DA method on the UV-visible spectral data shows a perfect discrimination of the three drugs with a sensitivity and specificity of 100%. The use of partial least square regression PLS shows high quantification performance of these molecules in solution represented by the low value of root mean square error of calibration (RMSEC) and root mean square error of cross validation (RMSCECV) on the one hand and the high value of R-square on the other hand. This study demonstrated the viability of UV-visible fingerprinting (routine approach) coupled with chemometric tools for the classification and quantification of chemotherapeutic drugs during clinical preparation.
Collapse
Affiliation(s)
- Aimen El Orche
- Laboratory of Chemical Processes and Applied Materials, Faculty of Science and Technology, Sultan Moulay Slimane University, Beni-Mellal, Morocco
| | - Casimir Adade Adade
- Team of Formulation and Quality Control of Health Products, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco
| | - Hafid Mefetah
- Rabat Pediatrics Hospital, Ibn Sina University Hospital Center, Rabat, Morocco
| | - Amine Cheikh
- Departement of Pharmacy, Faculty of Pharmacy, Abulcasis University, Rabat, Morocco
| | - Khalid Karrouchi
- Team of Formulation and Quality Control of Health Products, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco
| | - Miloud El Karbane
- Team of Formulation and Quality Control of Health Products, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco
| | - Mustapha Bouatia
- Team of Formulation and Quality Control of Health Products, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco
| |
Collapse
|
9
|
Dowek A, Lê LMM, Rohmer T, Legrand FX, Remita H, Lampre I, Tfayli A, Lavielle M, Caudron E. A mathematical approach to deal with nanoparticle polydispersity in surface enhanced Raman spectroscopy to quantify antineoplastic agents. Talanta 2020; 217:121040. [PMID: 32498908 DOI: 10.1016/j.talanta.2020.121040] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Revised: 04/08/2020] [Accepted: 04/13/2020] [Indexed: 01/04/2023]
Abstract
Antineoplastic agents are, for most of them, highly toxic drugs prepared at hospital following individualized prescription. To protect patients and healthcare workers, it is important to develop analytical tools able to identify and quantify such drugs on a wide concentration range. In this context, surface enhanced Raman spectroscopy (SERS) has been tested as a specific and sensitive technique. Despite the standardization of the nanoparticle synthesis, a polydispersity of nanoparticles in the suspension and a lack of reproducibility persist. This study focuses on the development of a new mathematical approach to deal with this nanoparticle polydispersity and its consequences on SERS signal variability through the feasibility of 5-fluorouracil (5FU) quantification using silver nanoparticles (AgNPs) and a handled Raman spectrophotometer. Variability has been maximized by synthetizing six different batches of AgNPs for an average size of 24.9 nm determined by transmission electron microscopy, with residual standard deviation of 17.0%. Regarding low performances of the standard multivariate data processing, an alternative approach based on the nearest neighbors were developed to quantify 5FU. By this approach, the predictive performance of the 5FU concentration was significantly improved. The mean absolute relative error (MARE) decreased from 16.8% with the traditional approach based on PLS regression to 6.30% with the nearest neighbors approach (p-value < 0.001). This study highlights the importance of developing mathematics adapted to SERS analysis which could be a step to overcome the spectral variability in SERS and thus participate in the development of this technique as an analytical tool in quality control to quantify molecules with good performances, particularly in the pharmaceutical field.
Collapse
Affiliation(s)
- Antoine Dowek
- Service de Pharmacie, Hôpital Européen Georges Pompidou, APHP.Centre Université-Paris, 20 Rue Leblanc, 75015, Paris, France; Université Paris-Saclay, Lipides, Systèmes Analytiques et Biologiques, 92296, Châtenay-Malabry, France.
| | - Laetitia Minh Mai Lê
- Service de Pharmacie, Hôpital Européen Georges Pompidou, APHP.Centre Université-Paris, 20 Rue Leblanc, 75015, Paris, France; Université Paris-Saclay, Lipides, Systèmes Analytiques et Biologiques, 92296, Châtenay-Malabry, France
| | - Tom Rohmer
- Inria, France; CMAP, Ecole Polytechnique, CNRS, Institut Polytechnique de Paris, France
| | | | - Hynd Remita
- Université Paris-Saclay, CNRS, Institut de Chimie Physique, UMR 8000, 91405, Orsay, France
| | - Isabelle Lampre
- Université Paris-Saclay, CNRS, Institut de Chimie Physique, UMR 8000, 91405, Orsay, France
| | - Ali Tfayli
- Université Paris-Saclay, Lipides, Systèmes Analytiques et Biologiques, 92296, Châtenay-Malabry, France
| | - Marc Lavielle
- Inria, France; CMAP, Ecole Polytechnique, CNRS, Institut Polytechnique de Paris, France
| | - Eric Caudron
- Service de Pharmacie, Hôpital Européen Georges Pompidou, APHP.Centre Université-Paris, 20 Rue Leblanc, 75015, Paris, France; Université Paris-Saclay, Lipides, Systèmes Analytiques et Biologiques, 92296, Châtenay-Malabry, France
| |
Collapse
|
10
|
Fedick PW, Pu F, Morato NM, Cooks RG. Identification and Confirmation of Fentanyls on Paper using Portable Surface Enhanced Raman Spectroscopy and Paper Spray Ionization Mass Spectrometry. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 2020; 31:735-741. [PMID: 32126777 DOI: 10.1021/jasms.0c00004] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Fentanyl and its analogues play a major role in the current opioid epidemic. In particular, these highly potent opioids have become a health hazard due to their use as additives in street drugs. Consequently, rapid on-site procedures for the analysis of this class of seized drugs are needed, especially considering the reported backlog of drug samples, which must undergo identification and confirmation tests to validate the presence of an illicit substance. Paper based devices are cheap sampling and analysis vehicles that have been shown capable of allowing rapid identification and confirmation of drugs of abuse. Modifying paper substrates by imprinting nanoparticles enables surface enhanced Raman spectroscopy (SERS) as well as a second analysis from the same substrate, namely paper spray ionization mass spectrometry. While such a procedure has been described for laboratory use, these illicit drug samples are typically collected in the field and this is where testing should be done. We combine paper SERS and paper spray MS on field-portable and commercial off-the-shelf (COTS) devices for the rapid and low-cost identification and confirmation of fentanyl and its analogues, enabling in situ analysis at the point of seizure of suspect samples. The commercial nature of both instruments moves this technology from the academic realm to a setting where the criminal justice system can realistically utilize it. The capabilities of this single-substrate dual-analyzer technique are further examined by sampling a variety of surfaces of forensic interest.
Collapse
Affiliation(s)
- Patrick W Fedick
- Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States
- Research Department, Chemistry Division, United States Navy-Naval Air Systems Command (NAVAIR), Naval Air Warfare Center, Weapons Division (NAWCWD), China Lake, California 93555, United States
| | - Fan Pu
- Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States
| | - Nicolás M Morato
- Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States
| | - R Graham Cooks
- Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States
| |
Collapse
|
11
|
Makki AA, Bonnier F, Respaud R, Chtara F, Tfayli A, Tauber C, Bertrand D, Byrne HJ, Mohammed E, Chourpa I. Qualitative and quantitative analysis of therapeutic solutions using Raman and infrared spectroscopy. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2019; 218:97-108. [PMID: 30954803 DOI: 10.1016/j.saa.2019.03.056] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/11/2018] [Revised: 02/06/2019] [Accepted: 03/17/2019] [Indexed: 06/09/2023]
Abstract
Anticancer drugs are prescribed and administrated to an increasing number of patients on a daily basis. As a consequence, a number of concerns have been raised about the patient health and safety in the case that the drugs administered are not at the required concentration or even worse not the correct ones. Quality control of therapeutic solutions has therefore been extensively implemented in hospital environments, in order to avoid any failure in the intense workflow faced by administering pharmacists. In the present study, infrared (IR) and Raman spectroscopy have been employed for the analysis of 3 commercially available therapeutic solutions TEVA®, MYLAN®, CERUBIDINE®, respectively containing doxorubicin, epirubicin and daunorubicin. They perfectly illustrate the analytical difficulties encountered, as these 3 chemotherapeutic drugs are isomers, hardly distinguishable with conventional approaches such as UV/VIS spectrometry. Any analytical failure to identify these molecules can lead to delays in patient treatment. While Partial Least Squares Regression analysis demonstrates that both Raman and IR can deliver satisfactory quantitative analysis in the clinical range, with respective Root Mean Square Error of Cross Validation (RMSECV) between 0.0127 - 0.0220 g·L-1 and 0.0573 - 0.0759 g·L-1, the identification rate between the 2 techniques differs substantially. Indeed, Principal Component Analysis - Factorial Discriminant Analysis (PCA-FDA) highlights that, depending on the data preprocessing applied to Raman spectra, the discrimination between the 3 drugs is decreased, with in some cases specificity and sensitivity below 50%. However, IR analysis displays encouraging results with an overall specificity and sensitivity between 99 and 100%, suggesting that reliable validation of the therapeutic solution for administration to patients can be achieved. IR and Raman spectroscopy could assist and support quality control of chemotherapeutic solutions prepared in personalised concentrations for each patient. The effective and reliable characterisation of therapeutic solutions could have a lot to offer to improve current practices in a near future.
Collapse
Affiliation(s)
- Alaa A Makki
- Université François-Rabelais de Tours, EA 6295 Nanomédicaments et Nanosondes, 31 avenue Monge, 37200 Tours, France; Department of Pharmacognosy, Faculty of Pharmacy, University of Gezira, Sudan
| | - Franck Bonnier
- Université François-Rabelais de Tours, EA 6295 Nanomédicaments et Nanosondes, 31 avenue Monge, 37200 Tours, France.
| | - Renaud Respaud
- Université François-Rabelais de Tours, UMR 1100, CHRU de Tours, Service de Pharmacie, F-37032 Tours, France
| | - Fatma Chtara
- Université François-Rabelais de Tours, EA 6295 Nanomédicaments et Nanosondes, 31 avenue Monge, 37200 Tours, France
| | - Ali Tfayli
- U-Psud, University of Paris-Saclay, Lip (Sys)2, EA7357, UFR-Pharmacy, Châtenay-Malabry, France
| | - Clovis Tauber
- UMR U1253 iBrain, Université de Tours, Inserm, 37032 Tours, France
| | | | - Hugh J Byrne
- FOCAS Research Institute, Technological University Dublin, Kevin Street, Dublin 8, Ireland
| | - Elhadi Mohammed
- Department of Pharmacognosy, Faculty of Pharmacy, University of Gezira, Sudan
| | - Igor Chourpa
- Université François-Rabelais de Tours, EA 6295 Nanomédicaments et Nanosondes, 31 avenue Monge, 37200 Tours, France
| |
Collapse
|
12
|
Lê L, Berge M, Tfayli A, Baillet Guffroy A, Prognon P, Dowek A, Caudron E. Quantification of gemcitabine intravenous drugs by direct measurement in chemotherapy plastic bags using a handheld Raman spectrometer. Talanta 2018; 196:376-380. [PMID: 30683379 DOI: 10.1016/j.talanta.2018.11.062] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2018] [Revised: 11/17/2018] [Accepted: 11/19/2018] [Indexed: 11/28/2022]
Affiliation(s)
- L Lê
- U-Psud, Univ. Paris-Saclay, Lip(Sys)2 Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France; European Georges Pompidou Hospital (AP-HP), Pharmacy Department, 20 rue Leblanc, 75015 Paris, France.
| | - M Berge
- European Georges Pompidou Hospital (AP-HP), Pharmacy Department, 20 rue Leblanc, 75015 Paris, France
| | - A Tfayli
- U-Psud, Univ. Paris-Saclay, Lip(Sys)2 Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France
| | - A Baillet Guffroy
- U-Psud, Univ. Paris-Saclay, Lip(Sys)2 Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France
| | - P Prognon
- U-Psud, Univ. Paris-Saclay, Lip(Sys)2 Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France; European Georges Pompidou Hospital (AP-HP), Pharmacy Department, 20 rue Leblanc, 75015 Paris, France
| | - A Dowek
- European Georges Pompidou Hospital (AP-HP), Pharmacy Department, 20 rue Leblanc, 75015 Paris, France
| | - E Caudron
- U-Psud, Univ. Paris-Saclay, Lip(Sys)2 Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France; European Georges Pompidou Hospital (AP-HP), Pharmacy Department, 20 rue Leblanc, 75015 Paris, France
| |
Collapse
|
13
|
Henriques J, Sousa J, Veiga F, Cardoso C, Vitorino C. Process analytical technologies and injectable drug products: Is there a future? Int J Pharm 2018; 554:21-35. [PMID: 30389475 DOI: 10.1016/j.ijpharm.2018.10.070] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2018] [Revised: 10/28/2018] [Accepted: 10/29/2018] [Indexed: 01/03/2023]
Abstract
Parametric release was the first subset of real time release testing (RTRT), applied to terminally sterilised injectable drug products. The objective was to offer the industry an alternative to the time and money consuming sterility testing, without compromising the sterility of the products. The rationale was that quality cannot be tested into products, instead it must be planned (the principle of quality by design, QbD). This can be implemented by setting appropriate in-process controls supported on process analytical technologies (PAT). Two of the most versatile and promising PAT tools are the near infrared spectroscopy (NIRS) and the Raman spectroscopy. However, their application to injectable drug product development and manufacturing has been scarce. This review has the objective to provide a framework for the practical implementation of the QbD approach to injectable formulations, including application of diverse risk assessment and factorial design tools. Finally, the actual application of PAT, namely NIRS and Raman spectroscopy, to injectable drug product analysis is addressed.
Collapse
Affiliation(s)
- João Henriques
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
| | - João Sousa
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal
| | - Francisco Veiga
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal
| | - Catarina Cardoso
- Laboratórios Basi, Parque Industrial Manuel Lourenço Ferreira, Lote 15, 3450-232 Mortágua, Portugal
| | - Carla Vitorino
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; Center for Neurosciences and Cell Biology (CNC), University of Coimbra, Rua Larga, Faculty of Medicine, Pólo I, 1st Floor, 3004-504 Coimbra, Portugal; REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
| |
Collapse
|
14
|
Vickers S, Bernier M, Zambrzycki S, Fernandez FM, Newton PN, Caillet C. Field detection devices for screening the quality of medicines: a systematic review. BMJ Glob Health 2018; 3:e000725. [PMID: 30233826 PMCID: PMC6135480 DOI: 10.1136/bmjgh-2018-000725] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2018] [Revised: 06/20/2018] [Accepted: 06/24/2018] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Poor quality medicines have devastating consequences. A plethora of innovative portable devices to screen for poor quality medicines has become available, leading to hope that they could empower medicine inspectors and enhance surveillance. However, information comparing these new technologies is woefully scarce. METHODS We undertook a systematic review of Embase, PubMed, Web of Science and SciFinder databases up to 30 April 2018. Scientific studies evaluating the performances/abilities of portable devices to assess any aspect of the quality of pharmaceutical products were included. RESULTS Forty-one devices, from small benchtop spectrometers to 'lab-on-a-chip' single-use devices, with prices ranging from US$20 000, were included. Only six devices had been field-tested (GPHF-Minilab, CD3/CD3+, TruScan RM, lateral flow dipstick immunoassay, CBEx and Speedy Breedy). The median (range) number of active pharmaceutical ingredients (APIs) assessed per device was only 2 (1-20). The majority of devices showed promise to distinguish genuine from falsified medicines. Devices with the potential to assay API (semi)-quantitatively required consumables and were destructive (GPHF-Minilab, PharmaChk, aPADs, lateral flow immunoassay dipsticks, paper-based microfluidic strip and capillary electrophoresis), except for spectroscopic devices. However, the 10 spectroscopic devices tested for their abilities to quantitate APIs required processing complex API-specific calibration models. Scientific evidence of the ability of the devices to accurately test liquid, capsule or topical formulations, or to distinguish between chiral molecules, was limited. There was no comment on cost-effectiveness and little information on where in the pharmaceutical supply chain these devices could be best deployed. CONCLUSION Although a diverse range of portable field detection devices for medicines quality screening is available, there is a vitally important lack of independent evaluation of the majority of devices, particularly in field settings. Intensive research is needed in order to inform national medicines regulatory authorities of the optimal choice of device(s) to combat poor quality medicines.
Collapse
Affiliation(s)
- Serena Vickers
- Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos
- Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
- Infectious Diseases Data Observatory (IDDO)/Worldwide Antimalarial Resistance Network (WWARN), University of Oxford, Oxford, UK
| | - Matthew Bernier
- School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia, USA
- Campus Chemical Instrument Center Mass Spectrometry and Proteomics Facility, The Ohio State University, Columbus, Ohio, USA
| | - Stephen Zambrzycki
- School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia, USA
| | - Facundo M Fernandez
- School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia, USA
| | - Paul N Newton
- Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos
- Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
- Infectious Diseases Data Observatory (IDDO)/Worldwide Antimalarial Resistance Network (WWARN), University of Oxford, Oxford, UK
| | - Céline Caillet
- Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos
- Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
- Infectious Diseases Data Observatory (IDDO)/Worldwide Antimalarial Resistance Network (WWARN), University of Oxford, Oxford, UK
| |
Collapse
|
15
|
Lê L, Berge M, Tfayli A, Prognon P, Caudron E. Discriminative and Quantitative Analysis of Antineoplastic Taxane Drugs Using a Handheld Raman Spectrometer. BIOMED RESEARCH INTERNATIONAL 2018; 2018:8746729. [PMID: 30065947 PMCID: PMC6051283 DOI: 10.1155/2018/8746729] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/28/2018] [Revised: 05/20/2018] [Accepted: 05/30/2018] [Indexed: 11/17/2022]
Abstract
This study was conducted to evaluate the ability of Raman spectroscopy (RS) to control antineoplastic preparations used for chemotherapy in order to ensure its physical and chemical qualities. Three taxane drugs: cabazitaxel (CBX), docetaxel (DCX) and paclitaxel (PCX) at therapeutic concentration ranges were analyzed using a handheld spectrometer at 785 nm. Qualitative and quantitative models were developed and optimized using a calibration set (n=75 per drug) by partial least square discriminant analysis and regression and validated using a test set (n=27 per drug). All samples were correctly assigned with an accuracy of 100%. Despite optimization, quantitative analysis showed limited performances at the lowest concentrations. The root mean square error of predictions ranged from 0.012 mg/mL for CBX to 0.048 mg/mL for DCX with a minimal coefficient of determination of 0.9598. The linearity range was validated from 0.175 to 0.30 mg/mL for CBX, from 0.40 to 1.00 mg/mL for DCX and from 0.57 to 1.20 mg/mL for PCX. Despite some limitations, this study confirms the potential of RS to control these drugs and also provides substantial advantages to secure the activity for healthcare workers. As a result of its rapidity and the uncomplicated use of a handheld instrument, RS appears to be a promising method to augment security of the medication preparation process in hospitals.
Collapse
Affiliation(s)
- Laetitia Lê
- U-Psud, Univ. Paris-Saclay, Lip(Sys), EA7357, UFR-Pharmacy, Châtenay-Malabry, France
- European Georges Pompidou Hospital (AP-HP), Pharmacy Department, Paris, France
| | - Marion Berge
- European Georges Pompidou Hospital (AP-HP), Pharmacy Department, Paris, France
| | - Ali Tfayli
- U-Psud, Univ. Paris-Saclay, Lip(Sys), EA7357, UFR-Pharmacy, Châtenay-Malabry, France
| | - Patrice Prognon
- U-Psud, Univ. Paris-Saclay, Lip(Sys), EA7357, UFR-Pharmacy, Châtenay-Malabry, France
- European Georges Pompidou Hospital (AP-HP), Pharmacy Department, Paris, France
| | - Eric Caudron
- U-Psud, Univ. Paris-Saclay, Lip(Sys), EA7357, UFR-Pharmacy, Châtenay-Malabry, France
- European Georges Pompidou Hospital (AP-HP), Pharmacy Department, Paris, France
| |
Collapse
|
16
|
Optimization of classification and regression analysis of four monoclonal antibodies from Raman spectra using collaborative machine learning approach. Talanta 2018; 184:260-265. [DOI: 10.1016/j.talanta.2018.02.109] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2017] [Revised: 02/24/2018] [Accepted: 02/27/2018] [Indexed: 01/26/2023]
|
17
|
Lê LMM, Berge M, Tfayli A, Zhou J, Prognon P, Baillet-Guffroy A, Caudron E. Rapid discrimination and quantification analysis of five antineoplastic drugs in aqueous solutions using Raman spectroscopy. Eur J Pharm Sci 2017; 111:158-166. [PMID: 28966101 DOI: 10.1016/j.ejps.2017.09.046] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2017] [Revised: 09/08/2017] [Accepted: 09/27/2017] [Indexed: 11/28/2022]
Abstract
The aim of this study was to assess the ability of Raman spectroscopy to discriminate and quantify five antineoplastic drugs in an aqueous matrix at low concentrations before patient administration. Five antineoplastic drugs were studied at therapeutic concentrations in aqueous 0.9% sodium chloride: 5-fluorouracil (5FU), gemcitabine (GEM), cyclophophamide (CYCLO), ifosfamide (IFOS) and doxorubicin (DOXO). All samples were packaged in glass vials and analyzed using Raman spectrometry from 400 to 4000cm-1. Discriminant analyses were performed using Partial Least Squares Discriminant Analysis (PLS-DA) and quantitative analyses using PLS regression. The best discrimination model was obtained using hierarchical PLS-DA models including three successive models for concentrations higher than the lower limit of quantification (0% of fitting and cross-validation error rate with an excellent accuracy of 100%). According to these hierarchical discriminative models, 90.8% (n=433) of external validation samples were correctly predicted, 2.5% (n=12) were misclassified and 6.7% (n=32) of the external validation set were not assigned. The quantitative analysis was characterized by the RMSEP that ranged from 0.23mg/mL for DOXO to 3.05mg/mL for 5FU. The determination coefficient (R2) was higher than 0.9994 for all drugs evaluated except for 5FU (R2=0.9986). This study provides additional information about the potential value of Raman spectroscopy for real-time quality control of cytotoxic drugs in hospitals. In some situations, this technique therefore constitutes a powerful alternative to usual methods with ultraviolet (UV) detection to ensure the correct drug and the correct dose in solutions before administration to patients and to limit exposure of healthcare workers during the analytical control process.
Collapse
Affiliation(s)
- Laetitia Minh Mai Lê
- U-Psud, Univ. Paris-Saclay, Lip(Sys)(2) Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France; European Georges Pompidou Hospital (AP-HP), Pharmacy Department, Paris, France.
| | - Marion Berge
- European Georges Pompidou Hospital (AP-HP), Pharmacy Department, Paris, France
| | - Ali Tfayli
- U-Psud, Univ. Paris-Saclay, Lip(Sys)(2) Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France
| | - Jiangyan Zhou
- U-Psud, Univ. Paris-Saclay, Lip(Sys)(2) Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France
| | - Patrice Prognon
- U-Psud, Univ. Paris-Saclay, Lip(Sys)(2) Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France; European Georges Pompidou Hospital (AP-HP), Pharmacy Department, Paris, France
| | - Arlette Baillet-Guffroy
- U-Psud, Univ. Paris-Saclay, Lip(Sys)(2) Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France
| | - Eric Caudron
- U-Psud, Univ. Paris-Saclay, Lip(Sys)(2) Chimie Analytique Pharmaceutique, EA7357, UFR-Pharmacy, Châtenay-Malabry, France; European Georges Pompidou Hospital (AP-HP), Pharmacy Department, Paris, France
| |
Collapse
|
18
|
Miloudi L, Bonnier F, Bertrand D, Byrne HJ, Perse X, Chourpa I, Munnier E. Quantitative analysis of curcumin-loaded alginate nanocarriers in hydrogels using Raman and attenuated total reflection infrared spectroscopy. Anal Bioanal Chem 2017; 409:4593-4605. [PMID: 28540461 DOI: 10.1007/s00216-017-0402-y] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2017] [Revised: 03/22/2017] [Accepted: 05/09/2017] [Indexed: 12/31/2022]
Abstract
Core-shell nanocarriers are increasingly being adapted in cosmetic and dermatological fields, aiming to provide an increased penetration of the active pharmaceutical or cosmetic ingredients (API and ACI) through the skin. In the final form, the nanocarriers (NC) are usually prepared in hydrogels, conferring desired viscous properties for topical application. Combined with the high chemical complexity of the encapsulating system itself, involving numerous ingredients to form a stable core and quantifying the NC and/or the encapsulated active without labor-intensive and destructive methods remains challenging. In this respect, the specific molecular fingerprint obtained from vibrational spectroscopy analysis could unambiguously overcome current obstacles in the development of fast and cost-effective quality control tools for NC-based products. The present study demonstrates the feasibility to deliver accurate quantification of the concentrations of curcumin (ACI)-loaded alginate nanocarriers in hydrogel matrices, coupling partial least square regression (PLSR) to infrared (IR) absorption and Raman spectroscopic analyses. With respective root mean square errors of 0.1469 ± 0.0175% w/w and 0.4462 ± 0.0631% w/w, both approaches offer acceptable precision. Further investigation of the PLSR results allowed to highlight the different selectivity of each approach, indicating only IR analysis delivers direct monitoring of the NC through the quantification of the Labrafac®, the main NC ingredient. Raman analyses are rather dominated by the contribution of the ACI which opens numerous perspectives to quantify the active molecules without interferences from the complex core-shell encapsulating systems thus positioning the technique as a powerful analytical tool for industrial screening of cosmetic and pharmaceutical products. Graphical abstract Quantitative analysis of encapuslated active molecules in hydrogel-based samples by means of infrared and Raman spectroscopy.
Collapse
Affiliation(s)
- Lynda Miloudi
- EA 6295 Nanomédicaments et Nanosondes, Université François-Rabelais de Tours, 31 avenue Monge, 37200, Tours, France
| | - Franck Bonnier
- EA 6295 Nanomédicaments et Nanosondes, Université François-Rabelais de Tours, 31 avenue Monge, 37200, Tours, France.
| | | | - Hugh J Byrne
- Dublin Institute of Technology (DIT), FOCAS Research Institute, Camden Row, Dublin, 8, Ireland
| | - Xavier Perse
- EA 6295 Nanomédicaments et Nanosondes, Université François-Rabelais de Tours, 31 avenue Monge, 37200, Tours, France
| | - Igor Chourpa
- EA 6295 Nanomédicaments et Nanosondes, Université François-Rabelais de Tours, 31 avenue Monge, 37200, Tours, France
| | - Emilie Munnier
- EA 6295 Nanomédicaments et Nanosondes, Université François-Rabelais de Tours, 31 avenue Monge, 37200, Tours, France
| |
Collapse
|
19
|
Lê LMM, Eveleigh L, Hasnaoui I, Prognon P, Baillet-Guffroy A, Caudron E. Rapid discrimination and determination of antibiotics drugs in plastic syringes using near infrared spectroscopy with chemometric analysis: Application to amoxicillin and penicillin. J Pharm Biomed Anal 2017; 138:249-255. [DOI: 10.1016/j.jpba.2017.02.019] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2016] [Revised: 02/08/2017] [Accepted: 02/09/2017] [Indexed: 10/20/2022]
|